An investigator received $4,000 of consulting income from a publicly traded drug company over the past 12 months. the investigator also owns stock in that company valued at $2,000. the investigator is submitting a grant to the national institutes of health that involves evaluating the effectiveness of a drug produced by the same drug company. what is true?